GlassScriptPhysician profile
Julia T Ehly
NPI 1548217177
$1,653.34
in general payments reported to CMS, 2019-2025
17 companies · $327 in 2025
The $327 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $68.31 · 2021: $96.29 · 2022: $192 · 2023: $234 · 2024: $400 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $486.04 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $276.77 | 2021-2024 | Azstarys |
| Tris Pharma INC | $164.07 | 2019 | |
| Cranial Technologies, INC | $134.48 | 2019-2025 | Doc Band |
| Pfizer INC. | $118.18 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $78.99 | 2020-2022 | |
| Sanofi Pasteur INC. | $64.85 | 2022-2025 | |
| Ironshore Pharmaceuticals INC. | $63.31 | 2019 | |
| Glaxosmithkline, LLC. | $60.10 | 2023-2025 | Bexsero, Pediarix, Rotarix |
| Biomarin Pharmaceutical INC. | $54.01 | 2025 | Voxzogo 1.2mg |
| Azurity Pharmaceuticals, INC. | $50.61 | 2025 | Alvesco |
| Sobi, INC | $25.68 | 2023 | |
| Shire North American Group INC | $17.85 | 2019 | |
| Collegium Pharmaceutical, INC. | $15.86 | 2025 | Jornay Pm |
| Exeltis, USA INC. | $14.94 | 2024 | Slynd |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $14.56 | 2025 | Xelstrym |
| Kaleo, INC. | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Ehly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.